Oluwamisimi Akinlolu: Rewiring Health Data from Nigeria to Global Oncology
At just 19 years old, while many of her peers were immersed in academic studies, Oluwamisimi Akinlolu embarked on a journey that would redefine health data management. While studying at Covenant University, she developed a diabetes management system that earned the Best Innovative Health Project of the Year award. This early success was not merely an achievement but a profound realization: the critical gap between health data and health decisions in Nigeria was not a technological issue but a design problem. This insight has propelled Akinlolu across continents and disciplines, from enhancing Nigeria's national immunization systems to influencing oncology strategies at a top global pharmaceutical company in the United States.
Early Career and Data Reconciliation
Akinlolu's initial work at eHealth4everyone, an organization supported by the Gates Foundation, exposed her to the chaotic state of Nigerian public health data. She observed an abundance of data from facility reports, demographic surveys, and partner datasets, yet these sources often provided conflicting figures for the same indicators. For federal and state decision-makers, the challenge shifted from data availability to data reliability, with planning proceeding despite these contradictions. As the principal architect of the Multi-Source Data Analytics and Triangulation platform (MSDAT), Akinlolu designed a system that harmonized these disparate data streams into a single, transparent framework. By standardizing definitions and applying consistent rules, MSDAT enabled policymakers to view numbers alongside their sources and discrepancies, leading to increased data usage, improved reporting accuracy, and adoption for immunization and primary healthcare planning across multiple government levels.
Mapping the Invisible and Tackling Vaccination Gaps
Her career advanced at Sydani Group, one of Africa's leading public health consulting organizations, where she rose from intern to Senior Analyst. Here, Akinlolu played a pivotal role in Nigeria's Zero-Dose Vaccination Strategy, targeting over two million children who had never received a vaccine. Faced with the challenge of locating these children amidst Nigeria's data limitations, she innovated a hybrid geospatial mapping model. This model integrated satellite imagery, health facility data, population density estimates, and vaccination coverage indicators to identify unvaccinated children and reveal systematically overlooked communities. This work formed the technical backbone of Nigeria's national zero-dose strategy and helped secure significant international funding.
COVID-19 Response and Social Listening Innovations
During the COVID-19 pandemic, Akinlolu's contributions expanded as she developed a social listening architecture for the Federal Ministry of Health and the National Primary Health Care Development Agency (NPHCDA). Embedded within the government's response infrastructure, she used machine learning to analyze social media, community reports, and communication channels, detecting patterns in public sentiment about vaccines. This system enabled health teams to craft targeted behavioral communication strategies, addressing vaccine hesitancy rooted in misinformation and distrust. She coordinated Advocacy, Communication, and Social Mobilization groups across all 36 states and the Federal Capital Territory, creating a national communications toolkit and training officers. Her efforts led to the establishment of the COVID-19 Rapid Response Immunization and Communication Centre (CRICC), which integrated social listening data with field reports and operational data, resulting in a more than 55% increase in vaccine uptake during coordinated campaigns.
Global Expansion and Oncology Impact
After transitioning to the United States, Akinlolu pursued an MBA at Johns Hopkins Carey Business School, focusing on health, technology, and innovation. Her current role as a data manager in the oncology business unit of a top global pharmaceutical company applies her expertise to high-stakes decision-making. She developed a Loss of Exclusivity forecasting framework that integrates prescription trends, competitive intelligence, and market dynamics to predict drug performance post-patent expiration. Beyond this, she has led initiatives to standardize data definitions, streamline reporting pipelines, and establish governance frameworks, ensuring decisions are based on coherent data rather than fragmented inputs.
Decision Architecture as a Lifeline for Public Health
In her soft-spoken manner, Akinlolu describes her work as decision architecture, following a systematic approach: identifying decision breakdowns, integrating fragmented data, standardizing definitions, embedding systems into workflows, and measuring outcomes. She emphasizes building systems that enhance decision reliability across contexts, from Nigerian public health to global pharmaceutical strategy. Outside her formal roles, she contributes as a peer reviewer for leading journals, a speaker on health communication, and a mentor to emerging professionals. Reflecting on her upbringing in a system where decisions were made on inconsistent data, Akinlolu's career is a dedicated effort to bridge the gap between data and action, ultimately saving lives in health systems where every decision counts.
